S&P 5007,623.68▼0.5% Nasdaq25,955.34▼0.2% Dow52,215.16▼1.2% Russell 2K2,775.90▼0.3% 10-Yr4.99%+4bp VIX19.45+0.42 WTI$103.44▲4.0% Gold$4,010.00▼1.2% EUR/USD1.120▼0.3% BTC$80,550▼0.9% Nikkei62,908▼2.6%
At close · Sat, Oct 24, 2026
Daily Market Updates.

ETFs & Funds

Home›ETFs & Funds›Equity Funds›What Is the Peptide Economy? Beyond the GLP-1 Boom

What Is the Peptide Economy? Beyond the GLP-1 Boom

Reported · Written up by our desk · Equity Funds

GLP-1 drugs have put peptides on investors’ radar, with Eli Lilly (LLY) and Novo Nordisk (NVO) leading the weight-loss market. But the investment opportunity extends beyond these treatments. According to industry figures, 36% of peptide medicine sales in 2025 came from diseases beyond obesity and diabetes, representing a market worth about $51 billion overall. Drug [...] The post What Is the Peptide Economy? Beyond the GLP-1 Boom appeared first on ETF Trends .

← Newer storyDisney’s multiplatform Super Bowl plan frustrates ABC affiliates

More like this

ETFs & FundsTreasury Yields Snapshot: October 23, 2026
ETFs & FundsWill Anthropic pull off a November IPO? Time is running out to file key paperwork.
ETFs & FundsInvestors piled a record sum into a leveraged semiconductor ETF last week. Things didn’t work out.
ETFs & FundsSeeking to Outpace the S&P 500? Give Dividends a Shot
ETFs & FundsSome Republicans are opposing Trump on tariffs. Maine’s Susan Collins just got him to back down on Canadian levies.

Sources

ETF TrendsWhat Is the Peptide Economy? Beyond the GLP-1 Boom

Get the close, explained.

One email every trading day: what moved, why it moved, and what's on deck tomorrow. Read in 3 minutes.

Free. Unsubscribe anytime.